BioSpace News Archive

Genetown

ImmuneID Announces Close of $50 Million Series A Financing to Develop Precision Immunology Therapeutics

ImmuneID, Inc. today announced that it has raised $50 million in Series A financing.

June 23, 2021
·
3 min read
Business

Abata Therapeutics Launches to Usher in New Era of Cell Therapy Using Targeted Regulatory T Cells to Treat Serious Autoimmune and Inflammatory Diseases

Third Rock Ventures today announced the launch of Abata Therapeutics.

June 23, 2021
·
8 min read
Drug Development

Gamida Cell Announces Publication in Blood, the Journal of the American Society of Hematology, of the First Pivotal Trial to Evaluate a Cell Therapy (Omidubicel)

Gamida Cell Announces Publication in Blood , the Journal of the American Society of Hematology, of the First Pivotal Trial to Evaluate a Cell Therapy (Omidubicel) for Patients with Blood Cancer who Require an Allogeneic Stem Cell Transplant

June 23, 2021
·
8 min read
Business

Brii Biosciences and VBI Vaccines Present Positive Data from Completed Phase 1b/2a Study on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 2021

Brii Biosciences today announced final results from a Phase 1b/2a study on BRII-179 (VBI-2601), a novel recombinant, protein-based immunotherapeutic candidate, in patients with chronic hepatitis B virus (HBV) infection.

June 23, 2021
·
7 min read
FDA

FDA Grants Bionaut Labs Orphan Drug Designation to BNL-101 for the Treatment of Malignant Gliomas in Pediatric and Adult Patients

First-in-class Bionaut™ treatment modality uses remote-controlled microscale robots to deliver biologics, nucleic acids, small molecule, gene or cellular therapies locally to targeted brain disease areas

June 23, 2021
·
4 min read
Bio NC

Heat Biologics Announces Significant Expansion of R&D and Pre-Clinical Capabilities at Corporate HeadquartersInvestments expected to accelerate development timelines and reduce development expenses

Heat Biologics, Inc. today announced the expansion of its research and development facilities in Morrisville, North Carolina.

June 23, 2021
·
3 min read
Business

Gritstone Announces Management Changes, Including the Appointment of Celia Economides as Chief Financial Officer

Gritstone bio, Inc., a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced the appointment of Celia Economides as executive vice president and chief financial officer.

June 23, 2021
·
5 min read
Qu Biologics Receives Additional Funding to Accelerate Clinical Development of Qu’s First-in-Class Immunotherapeutic for COVID-19 Prevention and Treatment

Qu Biologics Inc. is pleased to announce it is receiving advisory services and additional research and development funding of up to $1,971,195 funding from the National Research Council of Canada Industrial Research Assistance Program.

June 23, 2021
·
4 min read
Pharm Country

electroCore, Inc. Announces Exclusive Distribution Agreement with Kromax For Taiwan and China

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced it has entered into an agreement with Kromax International Corporation to serve as the exclusive distributor of the gammaCore Sapphire™ non-invasive vagus nerve stimulator in Taiwan and China.

June 23, 2021
·
5 min read
Drug Development

BioVie Receives FDA Guidance for Phase 3 Clinical Trial of BIV201 in HRS-AKICompany Planning a Potentially Pivotal Study in This Life-Threatening Complication of Ascites

BioVie Inc. (NASDAQ: BIVI) (“BioVie” or “Company”), a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and neurodegenerative disorders and certain cancers, today announced the results of a Type B meeting request submitted to the Food & Drug Administration (“FDA”) regarding its planned Phase 3 study of BIV201 (continuous infusion terlipressin) in hepatorenal syndrome–acute kidney injury (“HRS-AKI”).

June 23, 2021
·
4 min read